image
Financial Services - Asset Management - NASDAQ - US
$ 15.71
-6.93 %
$ 582 M
Market Cap
7.89
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Mar, 31, 2025.

The intrinsic value of one CCAP stock under the worst case scenario is HIDDEN Compared to the current market price of 15.7 USD, Crescent Capital BDC, Inc. is HIDDEN

This DCF valuation model was last updated on Mar, 31, 2025.

The intrinsic value of one CCAP stock under the base case scenario is HIDDEN Compared to the current market price of 15.7 USD, Crescent Capital BDC, Inc. is HIDDEN

This DCF valuation model was last updated on Mar, 31, 2025.

The intrinsic value of one CCAP stock under the best case scenario is HIDDEN Compared to the current market price of 15.7 USD, Crescent Capital BDC, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart CCAP

image
$20.0$20.0$19.5$19.5$19.0$19.0$18.5$18.5$18.0$18.0$17.5$17.5$17.0$17.0$16.5$16.5$16.0$16.0$15.5$15.515 Oct15 OctNov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '25
FINANCIALS
83.5 M REVENUE
-54.65%
-267 M OPERATING INCOME
-187.49%
73.6 M NET INCOME
-12.15%
58.9 M OPERATING CASH FLOW
-36.18%
0 INVESTING CASH FLOW
0.00%
-43.5 M FINANCING CASH FLOW
48.85%
12.4 M REVENUE
-76.01%
-48.4 M OPERATING INCOME
-96.01%
9.99 M NET INCOME
-34.56%
-2.89 M OPERATING CASH FLOW
-6.16%
0 INVESTING CASH FLOW
0.00%
4.97 M FINANCING CASH FLOW
110.98%
Balance Sheet Crescent Capital BDC, Inc.
image
Current Assets 10.1 M
Cash & Short-Term Investments 10.1 M
Receivables 12.2 M
Other Current Assets -12.2 M
Non-Current Assets 1.65 B
Long-Term Investments 1.6 B
PP&E 0
Other Non-Current Assets 42.5 M
96.82 %Total Assets$1.7b
Current Liabilities 0
Accounts Payable 26 M
Short-Term Debt 0
Other Current Liabilities -26 M
Non-Current Liabilities 0
Long-Term Debt 0
Other Non-Current Liabilities 0
Infinity %Total Liabilities$0.0
EFFICIENCY
Earnings Waterfall Crescent Capital BDC, Inc.
image
Revenue 83.5 M
Cost Of Revenue 0
Gross Profit 83.5 M
Operating Expenses 83.5 M
Operating Income -267 M
Other Expenses -341 M
Net Income 73.6 M
100m100m50m50m00(50m)(50m)(100m)(100m)(150m)(150m)(200m)(200m)(250m)(250m)(300m)(300m)84m084m(84m)(267m)341m74mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
100.00% GROSS MARGIN
100.00%
-320.16% OPERATING MARGIN
-320.16%
88.20% NET MARGIN
88.20%
9.94% ROE
9.94%
4.45% ROA
4.45%
-15.91% ROIC
-15.91%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Crescent Capital BDC, Inc.
image
100m100m50m50m00(50m)(50m)(100m)(100m)(150m)(150m)(200m)(200m)(250m)(250m)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income 73.6 M
Depreciation & Amortization 0
Capital Expenditures 0
Stock-Based Compensation 0
Change in Working Capital 2.04 M
Others -16.8 M
Free Cash Flow 58.9 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Crescent Capital BDC, Inc.
image
Wall Street analysts predict an average 1-year price target for CCAP of $18.5 , with forecasts ranging from a low of $18 to a high of $19 .
CCAP Lowest Price Target Wall Street Target
18 USD 14.58%
CCAP Average Price Target Wall Street Target
18.5 USD 17.76%
CCAP Highest Price Target Wall Street Target
19 USD 20.94%
Price
Max Price Target
Min Price Target
Average Price Target
2020202019191919181818181717171716161616May '24May '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26
4. DIVIDEND ANALYSIS
2.55% DIVIDEND YIELD
0.05 USD DIVIDEND PER SHARE
Q1
Q2
Q3
Q4
1.801.801.601.601.401.401.201.201.001.000.800.800.600.600.400.400.200.200.000.000.410.410.410.410.10.410.420.410.410.410.410.110.420.410.410.410.080.410.090.420.411.641.280.410.560.411.640.090.990.411.030.070.990.420.940.47202020202021202120222022202320232024202420252025
Download SVG
Download PNG
Download CSV
5. COMPETITION
slide 2 of 11
6. Ownership
Insider Ownership Crescent Capital BDC, Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Bargain Alert: I'm Buying These 7-11% Yields For Recurring Income Market volatility underscores the need for income-producing assets; Crescent Capital BDC and Omega Healthcare Investors offer compelling value with strong fundamentals and attractive yields. Crescent Capital BDC carries a diversified portfolio, high-quality secured debt, robust liquidity, and an 11% dividend yield while trading at a 15% discount to NAV. Omega Healthcare Investors benefits from a stable triple-net lease model, improving operator fundamentals, and a 7.3% dividend yield, with potential for capital appreciation. seekingalpha.com - 3 weeks ago
My Income Portfolio: Financial Awareness The essence of financial awareness is to realize that money can work for us through our investments. Understanding the value of money is the first step toward financial education, which leads to the selection of the most appropriate tools for developing that awareness. In my case, the instruments I have adopted are largely high-income vehicles, with monthly and, in some cases, quarterly distribution. seekingalpha.com - 3 weeks ago
Crescent Capital BDC: Q4 Earnings Showing Signs Of Weakness (Rating Downgrade) Crescent Capital BDC is downgraded due to a declining NII, and a less attractive discount to NAV. However, I don't see a reason for existing shareholders to sell. Despite recent weaknesses, CCAP maintains a strong dividend yield of 10.4%, supported by a healthy coverage rate and supplemental distributions for the next three quarters. The portfolio's high industry diversification and 90% first lien debt structure provide defensive measures, but higher interest rates challenge borrower performance. seekingalpha.com - 1 month ago
I'm Buying Magnificent Dividends Up To 9% Yield A contrarian mindset can help dividend investors find bargains, with Crescent Capital BDC and Cenovus Energy offering high yields after recent price drops. Crescent Capital BDC carries a diversified debt portfolio, strong dividend coverage, and a safe leverage profile, making it a compelling buy at a 9% discount to book value. Cenovus Energy's integrated operations and cost optimization efforts position it for long-term growth, with plans to return 100% of excess free cash flow to shareholders. seekingalpha.com - 1 month ago
Crescent Capital BDC, Inc. (CCAP) Q4 2024 Earnings Conference Call Transcript Crescent Capital BDC, Inc. (NASDAQ:CCAP ) Q4 2024 Earnings Conference Call February 20, 2025 ET Company Participants Dan McMahon - Head, IR Jason Breaux - CEO Henry Chung - President Gerhard Lombard - CFO Conference Call Participants Robert Dodd - Raymond James Mickey Schleien - Ladenburg Paul Johnson - KBW Operator Thank you for standing by. My name is Janine, and I will be your lead operator for today's call. seekingalpha.com - 1 month ago
Crescent Capital BDC (CCAP) Q4 Earnings and Revenues Lag Estimates Crescent Capital BDC (CCAP) came out with quarterly earnings of $0.55 per share, missing the Zacks Consensus Estimate of $0.56 per share. This compares to earnings of $0.61 per share a year ago. zacks.com - 1 month ago
Crescent Capital BDC, Inc. Reports Fourth Quarter 2024 Earnings Results; Declares a First Quarter Base Dividend of $0.42 Per Share and Series of Special Dividends LOS ANGELES, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC” or “Company”) (NASDAQ: CCAP) today reported net investment income of $2.40 per share and net income of $1.99 per share for the year ended December 31, 2024. For the quarter ended December 31, 2024, net investment income and net income per share were $0.55 and $0.27, respectively. Reported net asset value (NAV) per share was $19.98 at December 31, 2024. The Company announced that its Board of Directors (the “Board”) declared a first quarter 2025 regular cash dividend of $0.42 per share to stockholders of record as of March 31, 2025, payable on April 15, 2025, and a series of special cash dividends related to undistributed taxable income in the aggregate amount of $0.15 per share, to be paid in three equal quarterly installments of $0.05 per share.1 globenewswire.com - 1 month ago
3 Stocks From the Flourishing SBIC & Commercial Finance Industry A rise in financing demand across sectors on the back of economic resilience and relatively low rates will support companies like Main Street Capital, Barings BDC and Crescent Capital amid weakening asset quality. zacks.com - 1 month ago
Crescent Capital BDC (CCAP) Expected to Beat Earnings Estimates: Should You Buy? Crescent Capital BDC (CCAP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com - 1 month ago
Yield Hunting Part 8: 7%+ In 1 Year From Crescent Capital BDC Baby Bonds Crescent Capital BDC focuses on originating and investing in the debt of private middle-market U.S. companies, aiming for income and capital appreciation. The 5% baby bond FCRX trades at $24.54 with a yield to maturity of 7.16%, offering a 2% higher yield compared to sector benchmarks. CCAP's adjusted credit score equivalent for financial strength is Baa2. It has strong profitability, asset quality, and leverage, though it relies on refinancing unsecured notes. seekingalpha.com - 1 month ago
Crescent Capital BDC, Inc. Schedules Earnings Release and Conference Call to Discuss its Fourth Quarter and Fiscal Year Ended December 31, 2024 Financial Results LOS ANGELES, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC”) (NASDAQ: CCAP) today announced it will release its financial results for the fourth quarter and fiscal year ended December 31, 2024 on Wednesday, February 19, 2025 after market close. Crescent BDC invites all interested persons to attend its webcast/conference call on Thursday, February 20, 2025 at 12:00 p.m. Eastern Time to discuss its fourth quarter and year ended December 31, 2024 financial results. globenewswire.com - 2 months ago
Why Crescent Capital BDC (CCAP) is Poised to Beat Earnings Estimates Again Crescent Capital BDC (CCAP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. zacks.com - 2 months ago
8. Profile Summary

Crescent Capital BDC, Inc. CCAP

image
COUNTRY US
INDUSTRY Asset Management
MARKET CAP $ 582 M
Dividend Yield 2.55%
Description Crescent Capital BDC, Inc. is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
Contact 11100 Santa Monica Boulevard, Los Angeles, CA, 90025 https://www.crescentbdc.com
IPO Date Feb. 3, 2020
Employees None
Officers Mr. Gerhard Pieter Lombard Chief Financial Officer Mr. Raymond Feliciano Barrios Managing Director Mr. Daniel McMahon Senior Vice President & Head of Public Investor Relations Mr. Jason A. Breaux Chief Executive Officer Mr. George Paul Hawley J.D. Secretary & General Counsel Mr. Henry Sahn Chung President Mr. Kirill S. Bouek Controller Mr. Erik George Barrios Chief Compliance Officer